α-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson's disease

Mol Neurodegener. 2024 Oct 8;19(1):69. doi: 10.1186/s13024-024-00756-2.

Abstract

Background: Pathological accumulation of aggregated α-synuclein (aSYN) is a common feature of Parkinson's disease (PD). However, the mechanisms by which intracellular aSYN pathology contributes to dysfunction and degeneration of neurons in the brain are still unclear. A potentially relevant target of aSYN is the mitochondrion. To test this hypothesis, genetic and physiological methods were used to monitor mitochondrial function in substantia nigra pars compacta (SNc) dopaminergic and pedunculopontine nucleus (PPN) cholinergic neurons after stereotaxic injection of aSYN pre-formed fibrils (PFFs) into the mouse brain.

Methods: aSYN PFFs were stereotaxically injected into the SNc or PPN of mice. Twelve weeks later, mice were studied using a combination of approaches, including immunocytochemical analysis, cell-type specific transcriptomic profiling, electron microscopy, electrophysiology and two-photon-laser-scanning microscopy of genetically encoded sensors for bioenergetic and redox status.

Results: In addition to inducing a significant neuronal loss, SNc injection of PFFs induced the formation of intracellular, phosphorylated aSYN aggregates selectively in dopaminergic neurons. In these neurons, PFF-exposure decreased mitochondrial gene expression, reduced the number of mitochondria, increased oxidant stress, and profoundly disrupted mitochondrial adenosine triphosphate production. Consistent with an aSYN-induced bioenergetic deficit, the autonomous spiking of dopaminergic neurons slowed or stopped. PFFs also up-regulated lysosomal gene expression and increased lysosomal abundance, leading to the formation of Lewy-like inclusions. Similar changes were observed in PPN cholinergic neurons following aSYN PFF exposure.

Conclusions: Taken together, our findings suggest that disruption of mitochondrial function, and the subsequent bioenergetic deficit, is a proximal step in the cascade of events induced by aSYN pathology leading to dysfunction and degeneration of neurons at-risk in PD.

Keywords: Alpha-synuclein; Bioenergetics; Dopaminergic; Electrophysiology; Lewy pathology; Mitochondria; Parkinson’s disease; Pedunculopontine nucleus; Substantia Nigra; Transcriptome.

MeSH terms

  • Animals
  • Cholinergic Neurons* / metabolism
  • Cholinergic Neurons* / pathology
  • Dopaminergic Neurons* / metabolism
  • Dopaminergic Neurons* / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria* / metabolism
  • Mitochondria* / pathology
  • Parkinson Disease* / metabolism
  • Parkinson Disease* / pathology
  • alpha-Synuclein* / metabolism

Substances

  • alpha-Synuclein